In the face of looming revenue decline from blood cancer medication Revlimid, Indian pharma companies Natco Pharma and Dr.

Dr. Corey L. Hartman tells ESSENCE how this prescription can have long-term effects not just the body—but also on our skin.

New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish health officials are sounding the alarm as cases of NAION surge among ...